Of note, in S24 GIC treatment with DZNep led to a downregulation of the stem cell marker nestin (Figure 2F), which is in line with previous reports showing that EZH2 is crucial for maintaining a stem cell phenotype in malignant glioma [9], [10]. The gene discussed is NES; the disease is malignant glioma.